Manns M, Gerken G, Kyriatsoulis A, Trautwein C, Reske K, Meyer Zum Büschenfelde K H
I. Medizinische Klinik, Johannes Gutenberg-Universität Mainz, Federal Republic of Germany.
Hepatology. 1987 Sep-Oct;7(5):893-9. doi: 10.1002/hep.1840070517.
Antimitochondrial antibodies from patients with primary biliary cirrhosis react with different mitochondrial polypeptides as demonstrated by Western blots. The IgG fractions of a patient with primary biliary cirrhosis Stage I reacting exclusively with a pair of polypeptides at 48,000 daltons (p 48) on Western blot and from a patient with Stage III primary biliary cirrhosis reacting exclusively with a single 62,000 dalton polypeptide (p 62) were labeled with 125I; two radioimmunoassays were established detecting antimitochondrial antibodies against p 62 and p 48, respectively. Autologous sera blocked the assay, but the two reference sera did not block each other. Fourteen of 40 patients with primary biliary cirrhosis reacted with p 62, 6/40 with p 48 and 20 sera with both antigens. Sera from 200 patients with various hepatic and nonhepatic diseases were negative for anti-p 62 and anti-p 48. This collection of sera included 5 patients with nonhepatic autoimmune disorders, 3 with drug-induced pseudolupus syndrome and 2 with syphilis II, which were positive for antimitochondrial antibodies by immunofluorescence. Mitochondrial autoantigens p 62 and p 48 were both localized on mitoplasts, presumably inner mitochondrial membranes; they were thermolabile, trypsin- and chymotrypsin-sensitive, but resistant to DNAase, RNAase and neuraminidase treatments. In cesium chloride density gradients, p 62 floated at 1.28 gm per cm3 and p 48 at 1.30 gm per cm3. Thus, radioimmunoassays have been developed that specifically detect two distinct primary biliary cirrhosis-specific subtypes of antimitochondrial antibodies: anti-p 62 and anti-p 48. All primary biliary cirrhosis sera were positive for at least one of these antimitochondrial antibodies subtypes.(ABSTRACT TRUNCATED AT 250 WORDS)
原发性胆汁性肝硬化患者的抗线粒体抗体与不同的线粒体多肽发生反应,这在蛋白质免疫印迹法中得到了证实。一名原发性胆汁性肝硬化I期患者的IgG组分在蛋白质免疫印迹法中仅与一对48,000道尔顿(p48)的多肽发生反应,而一名原发性胆汁性肝硬化III期患者的IgG组分仅与一条62,000道尔顿的单一多肽(p62)发生反应,用125I对其进行标记;建立了两种放射免疫测定法,分别检测针对p62和p48的抗线粒体抗体。自体血清可阻断该测定,但两种参考血清彼此不发生阻断。40例原发性胆汁性肝硬化患者中,14例与p62发生反应,6/40与p48发生反应,20份血清与两种抗原均发生反应。200例患有各种肝脏和非肝脏疾病患者的血清抗p62和抗p48均为阴性。该血清样本包括5例非肝脏自身免疫性疾病患者、3例药物性假狼疮综合征患者和2例二期梅毒患者,他们通过免疫荧光法检测抗线粒体抗体呈阳性。线粒体自身抗原p62和p48均定位于线粒体膜(可能是线粒体内膜);它们对热不稳定,对胰蛋白酶和糜蛋白酶敏感,但对脱氧核糖核酸酶、核糖核酸酶和神经氨酸酶处理有抗性。在氯化铯密度梯度中,p62漂浮在1.28克/立方厘米,p48漂浮在1.30克/立方厘米。因此,已经开发出放射免疫测定法,可特异性检测抗线粒体抗体的两种不同的原发性胆汁性肝硬化特异性亚型:抗p62和抗p48。所有原发性胆汁性肝硬化血清中至少有一种抗线粒体抗体亚型呈阳性。(摘要截取自250字)